The orally-active P2X3 receptor antagonist, also known as BAY1817080, hit the main objective of the study, which was to reduce the average hourly cough frequency based on 24-hour sound recordings ...

Bayer has abandoned development of its investigational P2X3 receptor antagonist eliapixant, despite promising efficacy data in clinical trials, on what appears to be safety grounds. The decision ...

Steam inhalation can help open the nasal passages and get relief from the symptoms of a cold or sinus infection. Learn about the benefits and risks.